Viewing Study NCT06929195


Ignite Creation Date: 2025-12-24 @ 1:39 PM
Ignite Modification Date: 2025-12-28 @ 8:40 PM
Study NCT ID: NCT06929195
Status: RECRUITING
Last Update Posted: 2025-05-22
First Post: 2025-04-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Clinical Trial to Evaluate the Tolerance of TQB2210 Injection
Sponsor: Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module